Updated 2025 | Fact-checked | Medically Reviewed

Asthma is one of the most common chronic respiratory conditions, affecting millions of adults and children worldwide. Although inhalers, steroids, and biologic medications can help control symptoms, many patients continue to experience flare-ups, inflammation, and reduced quality of life.

In recent years, mesenchymal stem cell (MSC) therapy, especially using umbilical cord–derived MSCs (UC-MSCs), has emerged as a promising supportive option thanks to their anti-inflammatory and immune-modulating properties.

This article summarizes the latest research in simple, clear language to help patients and families understand whether MSC therapy may be appropriate.

What Is Asthma?

Asthma is a chronic inflammatory disorder of the airways. During an asthma attack, airway muscles tighten, the lining swells, and mucus production increases — leading to:

• Wheezing
• Coughing
• Shortness of breath
• Chest tightness

Asthma flare-ups may be triggered by:

• Allergens
• Air pollution
• Smoke exposure
• Viral infections
• Exercise
• Stress
• Weather changes

In severe cases, asthma attacks can be life-threatening.

Why Asthma Is Difficult to Control for Many Patients

Even with modern inhalers and biologic injections (e.g., anti-IgE or anti-IL-5 therapies), some patients still experience:

• Frequent flare-ups
• Persistent inflammation
• Steroid dependence
• Reduced lung function
• Sensitivity to triggers

This is because asthma involves complex immune dysregulation, not just airway constriction.

This is where MSC therapy is being researched as a way to target the root cause: chronic inflammation of the airways.

How Stem Cell Therapy May Help Asthma Patients

UC-MSCs have strong anti-inflammatory, immune-modulating, and tissue-repair properties. Researchers have studied their effects on allergic inflammation, airway hyperreactivity, and long-term airway remodeling.

Key Scientific Mechanisms

UC-MSCs may support asthma treatment by:

1. Reducing airway inflammation

Asthma features high levels of inflammatory cytokines:

• IL-4
• IL-5
• IL-13
• TNF-α
• IL-6

MSCs help reduce these cytokines and calm the immune response.

2. Regulating immune system activity

Asthma often involves:

• Overactive Th2 immune cells
• Eosinophil-driven inflammation
• Airway hypersensitivity

MSCs promote T-regulatory (Treg) cells, restoring immune balance.

3. Reducing airway remodeling

Chronic asthma leads to thickened airway walls and scarring.
MSC therapy may reduce fibrosis and support repair of airway epithelium.

4. Improving lung function

Clinical and animal studies show improvements in:

• Airway resistance
• FEV1 and FEV1/FVC ratios
• Oxygen exchange

5. Supporting repair after viral-induced asthma

Viral infections are a common trigger for asthma. MSCs may reduce post-viral inflammation and epithelial injury.

What Does the Research Show?

Numerous preclinical and human early-phase studies show that MSCs may reduce asthma severity.

• Reduction of eosinophilic inflammation

MSCs decrease eosinophils in asthma models — a critical marker of allergic inflammation.

• Improved airway hyperresponsiveness

Multiple studies show improved airway behavior after MSC infusion.

• Decreased mucus overproduction

MSCs help reduce hypersecretion from airway goblet cells.

• Promotion of healthy airway lining

UC-MSCs release growth factors (HGF, VEGF, IGF) that support repair of damaged airway tissue.

• Safety profile

Human studies so far show MSC therapy is safe, with mild temporary side effects. Although MSC therapy is not a cure, it may offer supportive benefits for patients who continue to struggle with inflammation despite medication.

What Improvements Do Patients Typically Notice?

Improvements vary, but many patients report:

• Fewer asthma attacks
• Less chest tightness
• Better tolerance to exercise
• Reduced reliance on inhalers
• Improved breathing stability
• Better sleep quality

Benefits usually appear gradually, from 4–12 weeks, as inflammation decreases.

Is MSC Therapy Safe for Asthma?

Research shows MSC therapy is generally well-tolerated.

Possible mild temporary effects:

• Fatigue
• Low-grade fever
• Injection-site discomfort

UC-MSCs are immune-privileged, meaning they do not trigger graft rejection in most patients. Safety is prioritized at every step.

Who Should Consider Stem Cell Treatment?

MSC therapy may be considered for individuals who:

• Have moderate to severe asthma
• Experience persistent inflammation despite treatment
• Want to reduce steroid dependence
• Have frequent flare-ups
• Have asthma triggered by inflammation or allergies
• Seek non-surgical, biologically guided treatment

Contraindications include active cancer or uncontrolled infection.

Asthma is a complex inflammatory disease that often requires more than inhalers or steroids to manage long-term. UC-MSC stem cell therapy offers a promising avenue for reducing airway inflammation, regulating immune responses, and supporting long-term lung health.

While not a cure, MSC therapy when performed using GMP–certified UC-MSCs under medical supervision may be a valuable supportive option for patients with chronic or difficult-to-control asthma.

About EDNA Wellness

EDNA Wellness is a private clinic specializing in Stem Cell Therapy in Bangkok, Thailand for Neurology & Stroke as well as Bones & Joints. Beyond rehabilitation, we also provide aesthetic and wellness treatments to support your full-body vitality. All delivered with expert care and compassion

For more information or inquiries, contact us via

LINE @ednawellness

WhatsApp +66 (0) 64 505 5599

www.ednawellness.com